Cohort profile: the SEROCoV-KIDS population-based cohort study and biobank on the impact of the COVID-19 pandemic in children and adolescents in Geneva, Switzerland
Résumé fourni par la source
Abstract Purpose The COVID-19 pandemic has had profound and multifaceted impacts on children and adolescents, exposing and deepening pre-existing inequalities while creating unique health, social, and educational challenges. In response to the limited evidence-based knowledge available, the SEROCoV-KIDS study was launched in 2021 as a prospective cohort and biobank to assess the pandemic’s effects on youth health and well-being. It focuses on the general population of Geneva, Switzerland, as well as subgroups with vulnerabilities, including prior SARS-CoV-2 infection, chronic health conditions, and socioeconomic disadvantage. Participants A total of 2199 children and adolescents, aged 6 months to 17 years, from 1340 households were enrolled in the SEROCoV-KIDS cohort, 2048 from the general population and 151 from clinics (i.e., children with chronic health conditions). At baseline, between December 2021 and June 2022, participants provided blood samples for serological testing and for long-term storage in the biobank, while comprehensive questionnaires were completed by a referent adult and adolescents aged 14 and older. Five follow-up online assessments were conducted until October 2025, addressing physical and mental health, development, quality of life, health behaviors, family dynamics, and education-related topics. The quantitative findings of the cohort study were enriched by a cross-sectional qualitative study conducted between October 2023 and March 2024, focusing specifically on socioeconomically disadvantaged populations. Findings to date In the population-based sample, 66.3% of participants tested seropositive for anti-SARS-CoV-2 nucleocapsid antibodies at baseline, and 4.1% reported symptoms consistent with post-COVID condition. Most children were minimally or not at all affected by the pandemic, showing good mental health over time. However, 8% of participants reported a positive pandemic impact, whereas 8–13% experienced negative impacts, mainly due to disrupted routines and reduced social support. Health behaviors like physical activity and sleep remained largely stable over the study period. Higher screen time at baseline was associated with poorer well-being. Children with chronic health conditions or experiencing socioeconomic and family disadvantage were disproportionately affected in terms of the health and psychosocial consequences of the pandemic. Future plans SEROCoV-KIDS demonstrates the value of child-focused cohorts for understanding the consequences of major societal events and for guiding evidence-based policy. Our next priority is to secure funding to prolong follow-up of this cohort and to maintain systematic surveillance of children and adolescents, so that emerging findings can directly inform public health and education policy over the coming years. Strengths and limitations of this study This large population-based pediatric cohort provides insights into the health and well-being of children and adolescents aged 6 months to 17 years at baseline, during and after the COVID-19 pandemic (from December 2021 to October 2025). This study integrates multifaceted findings on the general pediatric population and on subgroups of children with clinical and/or social vulnerabilities, combining quantitative and qualitative data to provide a deeper understanding of how the pandemic has affected their lives. This unique pediatric cohort and its associated biobank offer a rare opportunity to advance future pediatric research in Switzerland and abroad. Generalizability may be limited, as participating families tended to be more highly educated and somewhat more socioeconomically advantaged than the general Geneva population, despite nearly one-fifth reporting financial difficulties. The study was designed in response to the pandemic, and individual-level pre-pandemic data are lacking, which limits direct comparisons over time, relying instead on parent-reported perception of changes and impacts.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Cohort profile: the SEROCoV-KIDS population-based cohort study and biobank on the impact of the COVID-19 pandemic in children and adolescents in Geneva, Switzerland
- Date Crossref
- 16/01/2026
- Éditeur
- openRxiv
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.